Index of medicine substances

Lomefloxacin  •  Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones (J01MA07)

Lomitapide  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents (C10AX12)

Lomustine  •  Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas (L01AD02)

Lonapegsomatropin  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Somatropin and somatropin agonists (H01AC09)

Loncastuximab tesirin  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX22)

Loperamide  •  Alimentary tract and metabolism | Antipropulsives (A07DA03)

Loperamide + simethicone  •  Alimentary tract and metabolism | Antipropulsives (A07DA53)

Lopinavir + ritonavir  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR10)

Loratadine  •  Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use (R06AX13)

Loratadine + pseudoephedrine  •  Respiratory system | Nasal decongestants for systemic use | Sympathomimetics (R01BA52)

Lorazepam  •  Nervous system | Anxiolytics | Benzodiazepine derivatives (N05BA06)

Lorlatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Anaplastic lymphoma kinase (ALK) inhibitors (L01ED05)

Lornoxicam  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Oxicams (M01AC05)

Losartan  •  Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain (C09CA01)

Losartan + amlodipine  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB06)

Losartan + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA01)

Lovastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors (C10AA02)

Loxapine  •  Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines (N05AH01)

Lumacaftor + ivacaftor  •  Respiratory system | Other respiratory system products | Other respiratory system products (R07AX30)

Lumasiran  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products (A16AX18)

Lurasidone  •  Nervous system | Antipsychotics | Indole derivatives (N05AE05)

Luspatercept  •  Blood and blood forming organs | Other antianemic preparations (B03XA06)

Lutetium (177Lu) oxodotreotide  •  Various | Other therapeutic radiopharmaceuticals | Various therapeutic radiopharmaceuticals (V10XX04)

Lutetium (177Lu) vipivotide tetraxetane  •  Various | Other therapeutic radiopharmaceuticals | Various therapeutic radiopharmaceuticals (V10XX05)

Lutropin alfa  •  Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants (G03GA07)

Lynestrenol  •  Genito urinary system and sex hormones | Progestogens | Estren derivatives (G03DC03)